Effect of Single Dose Ketamine and Magnesium on Postoperative Pain in Patients Undergoing Bariatric Surgery

Completed · Not applicable · Has a placebo group

Conditions studied: Obesity

In brief

Opioid sparing analgesia is extremely important in the post-operative obese population. With more and more obese patients entering the operating room a multi-modal approach to analgesia is crucial. Finding effective alternatives to opioid therapy is the rationale of this proposal. Literature involving ketamine and magnesium in bariatric surgical patients is very sparse.

Key facts

Study ID

NCT02334059

Run by

Milton S. Hershey Medical Center

People needed

108

Starts

2015-11-01

Expected to finish

2019-03-13

Last updated by the study team

2020-06-01

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects undergoing laparoscopic sleeve gastrectomy
• Consenting adults age 18-80
• ASA II to ASA III
• Ability to understand and use a PCA
• Required to be hospitalized for at least 24 hours post-op

You may not qualify if…

• Patient refusal
• Chronic opiate use (daily opiate use for >3 months)
• Chronic Kidney disease (Creatinine>2)
• Known allergy or adverse effect of ketamine, magnesium or hydromorphone
• Patients with documented psychiatry (Maniac or MDP) history
• Patient unable to give informed consent
• Patient with limited or no English fluency

Where it is running

• Milton S.Hershey Medical Center — Hershey, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.